Table 4.
Met11Met | Met11Thr | Thr11Thr | |
---|---|---|---|
No. 191 | 59 (31%) | 104 (54%) | 28 (15%) |
Donor | |||
| |||
Age | 40 (25–47) | 33 (21–47) | 42 (27–49) |
Ethnicity | |||
Caucasian | 30 (51%) | 55 (53%) | 14 (50%) |
African American | 14 (28%) | 21 (20%) | 6 (21%) |
Hispanic | 11 (19%) | 24 (23%) | 3 (11%) |
Other | 4 (7%) | 4 (4%) | 5 (18%) |
Smoking | 18 (31%) | 34 (33%) | 11 (39%) |
Last pO2 | 453 (411–508) | 460 (411–507) | 411 (388–479) |
| |||
Recipient | |||
| |||
Age | 56 (43–61) | 57 (44–62) | 60 (39–64) |
Disease | |||
COPD | 21 (36%) | 28 (27%) | 7 (25%) |
ILD | 19 (32%) | 44 (42%) | 13 (46%) |
CF | 13 (22%) | 18 (17%) | 6 (21%) |
Other | 6 (10%) | 14 (13%) | 2 (7%) |
Bilateral lung-Tx | 53 (90%) | 69 (66%) | 19 (68%) |
CMV mismatch | 19 (32%) | 21 (20%) | 12 (43%) |
PGD-3 at 72 h | 6 (10%) | 8 (8%) | 2 (7%) |
PGD, primary graft dysfunction score 3. Numbers in brackets show 25th to 75th percentile range.